GE HealthCare Technologies/$GEHC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About GE HealthCare Technologies
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Ticker
$GEHC
Sector
Primary listing
Employees
53,000
Headquarters
Website
GEHC Metrics
BasicAdvanced
$34B
15.52
$4.83
1.28
$0.14
0.19%
Price and volume
Market cap
$34B
Beta
1.28
52-week high
$94.80
52-week low
$57.65
Average daily volume
3.2M
Dividend rate
$0.14
Financial strength
Current ratio
1.181
Quick ratio
0.853
Long term debt to equity
84.198
Total debt to equity
105.127
Dividend payout ratio (TTM)
2.80%
Interest coverage (TTM)
7.41%
Profitability
EBITDA (TTM)
3,626
Gross margin (TTM)
40.80%
Net profit margin (TTM)
10.95%
Operating margin (TTM)
15.08%
Effective tax rate (TTM)
17.66%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
5.45%
Return on equity (TTM)
24.45%
Valuation
Price to earnings (TTM)
15.515
Price to revenue (TTM)
1.691
Price to book
3.42
Price to tangible book (TTM)
-7.4
Price to free cash flow (TTM)
24.452
Free cash flow yield (TTM)
4.09%
Free cash flow per share (TTM)
3.065
Dividend yield (TTM)
0.18%
Forward dividend yield
0.19%
Growth
Revenue change (TTM)
3.51%
Earnings per share change (TTM)
32.35%
3-year revenue growth (CAGR)
4.01%
What the Analysts think about GEHC
Analyst ratings (Buy, Hold, Sell) for GE HealthCare Technologies stock.
Bulls say / Bears say
After Q3 results, GE HealthCare lifted its 2025 adjusted EPS guidance to $4.51–$4.63 per share—and beat revenue forecasts with $5.14 billion in sales—driven by robust U.S. and EMEA imaging demand up 5%. (Reuters)
The company has since raised its outlook again, forecasting ~3% organic revenue growth, $4.43–$4.63 in EPS, and at least $1.4 billion in free cash flow after gaining clearer visibility on tariff impacts. (WSJ)
In Q3, orders climbed 6% year-over-year and pharmacological diagnostics sales surged 20%, while the book-to-bill ratio hit 1.1, signaling strong backlog expansion and multi-segment demand. (Barron's)
China sales fell 3% to $547 million in Q3, hurt by Beijing's anti-corruption campaign and delayed stimulus measures, pointing to regional demand weakness. (Reuters)
GE HealthCare expects a $265 million annual tariff hit—equivalent to a $0.06 EPS drag—including fresh levies on Indian imports and metal derivatives, which will continue to pressure margins. (Reuters)
In late April, GE HealthCare slashed its full-year profit outlook to $3.90–$4.10 per share from $4.61–$4.75, underscoring persistent cost and tariff headwinds despite recent operational gains. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 1 Nov 2025.
GEHC Financial Performance
Revenues and expenses
GEHC Earnings Performance
Company profitability
GEHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for GE HealthCare Technologies stock?
GE HealthCare Technologies (GEHC) has a market cap of $34B as of November 03, 2025.
What is the P/E ratio for GE HealthCare Technologies stock?
The price to earnings (P/E) ratio for GE HealthCare Technologies (GEHC) stock is 15.52 as of November 03, 2025.
Does GE HealthCare Technologies stock pay dividends?
Yes, the GE HealthCare Technologies (GEHC) stock pays dividends to shareholders. As of November 03, 2025, the dividend rate is $0.135 and the yield is 0.19%. GE HealthCare Technologies has a payout ratio of 2.8% on a trailing twelve-month basis.
When is the next GE HealthCare Technologies dividend payment date?
The next GE HealthCare Technologies (GEHC) dividend payment is scheduled for November 14, 2025.
What is the beta indicator for GE HealthCare Technologies?
GE HealthCare Technologies (GEHC) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.